Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Systematic Review And Meta-analysis Of Tumor Biomarkers In Predicting Prognosis In Esophageal Cancer
M. Chen, J. Huang, Zhenli Zhu, J. Zhang, K. Li
Published 2013 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
BackgroundEsophageal cancer (EC) is a frequently occurring cancer with poor prognosis despite combined therapeutic strategies. Many biomarkers have been proposed as predictors of adverse events. We sought to assess the prognostic value of biomarkers in predicting the overall survival of esophageal cancer and to help guide personalized cancer treatment to give patients the best chance at remission.MethodsWe conducted a systematic review and meta-analysis of the published literature to summarize evidence for the discriminatory ability of prognostic biomarkers for esophageal cancer. Relevant literature was identified using the PubMed database on April 11, 2012, and conformed to the REMARK criteria. The primary endpoint was overall survival and data were synthesized with hazard ratios (HRs).ResultsWe included 109 studies, exploring 13 different biomarkers, which were subjected to quantitative meta-analysis. Promising markers that emerged for the prediction of overall survival in esophageal squamous cell cancer included VEGF (18 eligible studies, n = 1476, HR = 1.85, 95% CI, 1.55-2.21), cyclin D1 (12 eligible studies, n = 1476, HR = 1.82, 95% CI, 1.50-2.20), Ki-67 (3 eligible studies, n = 308, HR = 1.11, 95% CI, 0.70-1.78) and squamous cell carcinoma antigen (5 eligible studies, n = 700, HR = 1.28, 95% CI, 0.97-1.69); prognostic markers for esophageal adenocarcinoma included COX-2 (2 eligible studies, n = 235, HR = 3.06, 95% CI, 2.01-4.65) and HER-2 (3 eligible studies, n = 291, HR = 2.15, 95% CI, 1.39-3.33); prognostic markers for uncategorized ECs included p21 (9 eligible studies, n = 858, HR = 1.27, 95% CI, 0.75-2.16), p53 (31 eligible studies, n = 2851, HR = 1.34, 95% CI, 1.21-1.48), CRP (8 eligible studies, n = 1382, HR = 2.65, 95% CI, 1.64-4.27) and hemoglobin (5 eligible studies, n = 544, HR = 0.91, 95% CI, 0.83-1.00).ConclusionsAlthough some modest bias cannot be excluded, this review supports the involvement of biomarkers to be associated with EC overall survival.
This paper references
Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.
P. Liu (2009)
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma
A. Rosato (2006)
Clinical application of malignancy potential grading as a prognostic factor of human esophageal cancers.
H. Shiozaki (2000)
Prognostic value of DNA index, S‐phase fraction and p53 protein accumulation after surgical resection of esophageal squamous‐cell carcinomas in Thailand
A. Chanvitan (1995)
Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.
B. G. Gould Rothberg (2009)
Associ - ation of p 53 / p 21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients
N Taghavi (2010)
Radiotherapy for oesophagus carcinoma: the impact of p53 on treatment outcome.
J. Pomp (1998)
Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis
D. Güner (2003)
Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer.
S. Zenda (2008)
Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus.
C. H. Shih (2000)
Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus.
I. Gockel (2006)
Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus
西岡 清訓 (2002)
Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma.
C. Kunisaki (2006)
Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma
S. Takeno (2002)
Expression of cell cycle regulators p 21 and p 27 as predictors of disease outcome in colorectal carcin
J Al-Maghrabi (2012)
Survivin expression in oesophageal squamous cell carcinoma: its prognostic impact and splice variant expression.
S. Takeno (2010)
Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis.
Xi-jiang Zhao (2003)
Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma.
K-F Hsu (2009)
Immunohistochemical evaluation for P 53 and VEGF ( Vascular Endothelial Growth Factor ) is not prognostic for long term survival in end stage esophageal adenocarcinoma
p 21 Waf 1 / Cip 1 expression is a prognostic marker in curatively resected esophageal squamous cell carcinoma , but not p 27 Kip 1 , p 53 , or Rb
ME Nita (1999)
Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma
K. Mimura (2005)
Cell cycle-regulated factors in esophageal cancer.
M. Shinohara (2002)
E-cadherin expression in patients with esophageal squamous cell carcinoma: promoter hypermethylation, Snail overexpression, and clinicopathologic implications.
S. Takeno (2004)
Clinicopathological significance of cyclooxygenase-2 and cell cycle-regulatory proteins expression in patients with esophageal squamous cell carcinoma.
J. Huang (2012)
Expression of hypoxia - inducible factor ( HIF ) - 1 alpha and vascular endothelial growth factor ( VEGF ) - D as outcome predictors in resected esophageal squamous cell carcinoma
C Tzao (2008)
Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression
H. Hugo (2007)
Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma
H. Shimada (2002)
Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma.
Y. Chung (2011)
Mucin 1 and Vascular Endothelial Growth Factor C Expression Correlates with Lymph Node Metastatic Recurrence in Patients with N0 Esophageal Cancer After Ivor-Lewis Esophagectomy
Z. Sun (2010)
Clinical significance of serum carci - noembryonic antigen , carbohydrate antigen 19 – 9 , and squamous cell carcinoma antigen levels in esophageal cancer patients
S Kosugi (2004)
Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas
H. Yoon (2012)
Elevation of preoperative serum C‐reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma
H. Shimada (2003)
alpha-catenin is a significant prognostic factor than E-cadherin in esophageal squamous cell carcinoma.
T. Setoyama (2007)
Nuclear expression of 14-3-3 sigma is related to prognosis in patients with esophageal squamous cell carcinoma.
H. Okumura (2010)
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
I. Chu (2008)
Prognostic significance of cyclinD 1 amplification and the co - alteration of cyclinD 1 / pRb / ppRb in patients with esophageal squamous cell carcinoma
A Chanvitan (2012)
Preoperative survivin mRNA detection in peripheral blood is an independent predictor of outcome in esophageal carcinoma.
A. Hoffmann (2010)
Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma.
T. Nozoe (2001)
Expression of heat shock protein 70 in grossly resected esophageal squamous cell carcinoma.
T. Noguchi (2002)
Prog - nostic significance of CyclinD 1 and E - Cadherin in patients with esophageal squamous cell carcinoma : multiinstitutional retrospective analysis
M Ikeguchi (2001)
Expression of Vascular Endothelial Growth Factor as a Prognostic Factor in Node-positive Squamous Cell Carcinoma in the Thoracic Esophagus: Long-term Follow-up Study
Y. Ogata (2003)
Significant Host- and Tumor-Related Factors for Predicting Prognosis in Patients With Esophageal Carcinoma
M. Ikeda (2003)
Bias in meta-analysis detected by a simple, graphical test
M. Egger (1997)
Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma
K. Sasaki (2009)
Measuring inconsistency in meta-analyses
J. Higgins (2003)
Expression of p21(Waf1/Cip1) predicts response and survival of esophageal cancer patients treated by chemoradiotherapy.
T. Nakamura (2004)
Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer
M. Chen (2013)
Prolyl isomerase Pin 1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD 1 expression
Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
H. Shimada (2003)
Correlation of p 53 , MDM 2 and p 14 ( ARF ) protein expression in human esophageal squamous cell carcinoma
Cheng T-H (2009)
Cyclin D 1 overexpression as a prognostic factor in patients with esophageal carcinoma
M Shinohara (2001)
Contributions in the domain of cancer research: Review¶Negative regulators of cyclin-dependent kinases and their roles in cancers
M. Lee (2001)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
A. Harris (2005)
Prognostic Significance of Dysadherin Expression in Esophageal Squamous Cell Carcinoma
Y. Shimada (2004)
Serum p53 autoantibodies as prognostic marker in patients with oesophageal carcinoma.
A. Bergqvist (2001)
Prognostic Value of Serum Tumor Markers in Patients with Lung Cancer
K. Hatzakis (2002)
Hallmarks of Cancer: The Next Generation
D. Hanahan (2011)
Prognostic value of cell adhesion in esophageal adenocarcinomas.
D. Falkenback (2008)
Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus.
T. Nozoe (2005)
Prognostic Significance of Serine 392 Phosphorylation in Overexpressed p53 Protein in Human Esophageal Squamous Cell Carcinoma
M. Matsumoto (2004)
Prognostic role of cyclooxygenase‐2 in neoadjuvant‐treated patients with squamous cell carcinoma of the esophagus
A. Sivula (2005)
Micro - vessel density and VEGF expression are prognostic factors in colorectal cancer . Meta - analysis of the literature
G DesGuetz (2006)
Prediction of CCND 1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma
MT Wang (2010)
In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis.
S. Uchida (1998)
HER-2 overexpression (3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival.
M. Dreilich (2006)
Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma.
S. Mega (2006)
Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens.
T. Kii (2007)
No prognostic significance of p53 expression in esophageal squamous cell carcinoma
A. Kanamoto (1999)
Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis
J. Chen (2011)
Prognostic Value of p27Kip1 and CyclinD1 Expression in Esophageal Cancer
A. Itami (1999)
Tumor marker expression is predictive of survival in patients with esophageal cancer.
T. Aloia (2001)
The role of cystatin C and the angiogenic cytokines VEGF and bFGF in patients with esophageal carcinoma
M. Dreilich (2005)
Discovery of New Molecular Subtypes in Oesophageal Adenocarcinoma
D. Berg (2011)
Cyclin D 1 expression and retinoblastoma gene protein ( pRB ) expression in esophageal squamous cell carcin
S Nagasawa (2001)
p 53 Mutational Status Improves Estimation of Prognosis in Patients with Curatively Resected Adenocarcinoma in Barrett ’ s Esophagus 1
P. Schneider (2000)
Systematic reviews of evaluations of prognostic variables
D. Altman (2001)
Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma.
S. Natsugoe (2007)
p 53 alterations in oesophageal cancer : association with clinicopatho - logical features , risk factors , and survival
J Pomp (1998)
Prognostic significance of serum p 53 antibody in patients with esophageal squamous cell carcinoma
H Shimada (2002)
Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus
P. Bhandari (2005)
The prognostic significance of cell cycle markers in esophageal cancer after neoadjuvant chemotherapy.
M. Yasunaga (1999)
Survivin, cancer networks and pathway-directed drug discovery
D. Altieri (2008)
Impact of VEGF and VEGF Receptor 1 (FLT1) Expression on the Prognosis of Stage III Esophageal Cancer Patients after Radiochemotherapy*
D. Rades (2008)
Positive correlation between p 27 Kip 1 expression and progression of human esophageal squamous cell carcinoma
T Anayama (1998)
Significance of HER2 Low-Level Copy Gain in Barrett's Cancer: Implications for Fluorescence In situ Hybridization Testing in Tissues
S. Rauser (2007)
Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus.
Po-Kuei Hsu (2008)
Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
H. Kato (2002)
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis.
E. Steels (2001)
Perioperative Changes of Serum p53 Antibody Titer is a Predictor for Survival in Patients with Esophageal Squamous Cell Carcinoma
H. Shimada (2008)
The prognostic significance of p 53 , p 21 ( Waf 1 / Cip 1 ) , and cyclin D 1 protein expression in esophageal cancer patients
T Hirai (1999)
Prognostic value of p 53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the esophagus
AR Rosa (2003)
Expression of RCAS 1 in esophageal squamous cell carcinoma is associated with a poor prognosis
H Kato (2005)
Meta-analysis in clinical trials.
R. Dersimonian (1986)
Association of C-Reactive Protein Levels and Long-Term Survival after Neoadjuvant Therapy and Esophagectomy for Esophageal Cancer
U. Zingg (2009)
Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy
J. Valencia Julve (2006)
Survivin Gene Expression Positively Correlates with Proliferative Activity of Cancer Cells in Esophageal Cancer
M. Ikeguchi (2003)
Expression of p 21 WAF 1 / Cip 1 in the p 53-dependent Pathway Is Related to Prognosis in Patients with Advanced Esophageal Carcinoma 1
S. Natsugoe (1999)
The role of C-reactive protein as a prognostic indicator in advanced cancer
Fade Mahmoud (2002)
Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus.
C. Buskens (2002)
Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma
H. Shimada (2001)
Deregulated p 21 ( WAF 1 ) over - expression impacts survival of surgically resected esophageal squamous cell carcinoma patients
Goan Y-G (2005)
Prognostic value of DNA ploidy and cerbB‐2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus
T. Nakamura (1994)
PML protein as a prognostic molecular marker for patients with esophageal squamous cell carcinomas receiving primary surgery
C. Yen (2011)
Loss of p 27 ( KIP 1 ) expression predicts poor prognosis in patients with esophageal squamous cell carcinoma
A Shamma (2000)
Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy
P. Blanchard (2011)
Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
K. Gaarenstroom (2000)
Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis
T. Tanaka (2010)
Prognostic Significance of Vascular Endothelial Growth Factor Expression and Microvessel Density in Esophageal Squamous Cell Carcinoma: Comparison With Positron Emission Tomography
J. Choi (2006)
Operating characteristics of a rank correlation test for publication bias.
C. Begg (1994)
Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy.
Chang-Yu Wang (2009)
Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus - significance as a tumor marker.
T. Nozoe (2003)
VEGF as a Predictor for Response to Definitive Chemoradiotherapy and COX-2 as a Prognosticator for Survival in Esophageal Squamous Cell Carcinoma
M. Yoon (2011)
Clinical Significance of Osteopontin in Esophageal Squamous Cell Carcinoma: Comparison with Common Tumor Markers
Y. Shimada (2005)
Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology
Y. Shimada (1999)
Evaluating the Quality of Research into a Single Prognostic Biomarker: A Systematic Review and Meta-analysis of 83 Studies of C-Reactive Protein in Stable Coronary Artery Disease
H. Hemingway (2010)
Bias in meta-analysis detected by a simple, graphical test. Increase in studies of publication bias coincided with increasing use of meta-analysis.
F. Song (1998)
p53, p21(Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer.
M. Kuwahara (1999)
Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities.
M. Sarbia (1998)
Clinical prognostic values of vascular endothelial growth factor, microvessel density,and p53 expression in esophageal carcinomas.
M. Ahn (2002)
p 53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus
M Yamasaki (2010)
Intratumoral lym - phangiogenesis of esophageal squamous cell carcinoma and relationship with regulatory factors and prognosis
A Inoue (2008)
Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities
M. Sarbia (1999)
COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer
J. Mrena (2009)
Prognostic significance of thymidine phosphorylase and p53 co-expression in esophageal squamous cell carcinoma.
Oota Makoto (2002)
Newly developed assay measuring cytokeratins 8, 18 and 19 in serum is correlated to survival and tumor volume in patients with esophageal carcinoma.
D. Brattström (2005)
Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy.
M. Gibson (2003)
Cell adhesion system and human cancer morphogenesis
S. Hirohashi (2003)
Serum vascular endothelial growth factors C and D in patients with oesophageal cancer.
M. Kozlowski (2010)
Tumoral CRP expression in thoracic esophageal squamous cell cancers is associated with poor outcomes
Toshinobu Nakatsu (2012)
This paper is referenced by
Consensus statement of the Hellenic and Cypriot Oesophageal Cancer Study Group on the diagnosis, staging and management of oesophageal cancer
A. Fountoulakis (2019)
Clinical and Prognostic Implications of P21 (WAF1/CIP1) Expression in Patients with Esophageal Cancer: A Systematic Review and Meta-Analysis
Junbo Wu (2020)
Factores pronósticos asociados a la supervivencia en el cáncer de esófago
Elena Rodríguez Camacho (2014)
Analytical assessment of the novel Maglumi squamous cell carcinoma antigen (SCCA) immunoluminometric assay.
Mariella Dipalo (2015)
Correction: Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women
W. Wulaningsih (2016)
Diabetes and Incidence and Prognosis of Surgical Malignancies
Kirstin de Bruijn (2015)
Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma
Dan-hong Zhang (2015)
The prognostic implication of pre-treatment hemoglobin levels in esophageal cancer patients: A systematic review and meta-analysis
Zihan Ran (2020)
Prognostic markers in esophageal cancer: from basic research to clinical use
L. Hong (2015)
Africa’s oesophageal cancer corridor: Do hot beverages contribute?
M. O. Munishi (2015)
Clinical-Pathological Characteristics and Prognosis of a Cohort of Oesophageal Cancer Patients: a Competing Risks Survival Analysis
E. Rodríguez-Camacho (2015)
Low preoperative albumin-globulin score predicts favorable survival in esophageal squamous cell carcinoma
F. Zhang (2016)
Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review
Chunni Wang (2017)
Prognostic Significance of C-reactive Protein-to-prealbumin Ratio in Patients with Esophageal Cancer.
T. Matsunaga (2020)
Local Synthesis of Pepsin in Barrett’s Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma
T. Samuels (2015)
Lessons from pathological analysis of recurrent early esophageal squamous cell neoplasia after complete endoscopic radiofrequency ablation.
W. Wang (2018)
Opioids and cancer recurrence
R. Juneja (2014)
High preoperative plasma fibrinogen and serum albumin score is associated with poor survival in operable esophageal squamous cell carcinoma.
Shu-yan Sun (2019)
Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma
LH McCormick Matthews (2015)
Tumour‐associated antigens and their anti‐cancer applications
C. Liu (2017)
HER2 expression in gastric and oesophageal cancer: a meta-analytic review.
V. Nagaraja (2015)
Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma
Z. Tong (2017)
Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer
M. Chen (2013)
Serum Fibrinogen Is An Independent Prognostic Factor In Operable Esophageal Squamous Carcinoma: A Real-World Study
Y. Zheng (2019)
Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studies
Song Wen (2015)
Prognostic role of human papillomavirus in esophageal cancer : a meta-analysis
T. Zheng (2016)
Gastroesophageal Mucosal Injury after Cholecystectomy: An Indication for Surveillance?
Syeda Nadia Shah Gilani (2017)
Absence or low IGF‐1R‐expression in esophageal adenocarcinoma is associated with tumor invasiveness and radicality of surgical resection
K. D. De Bruijn (2015)
The prognostic value of TP 53 mutations in oesophageal adenocarcinoma : a systematic review and meta-analysis
O. Fisher (2016)
Construction of disease-specific transcriptional regulatory networks identifies co-activation of four gene in esophageal squamous cell carcinoma.
Y. Zhao (2017)
Systemic treatment of gastric and esophageal adenocarcinoma in elderly patients.
L. Balducci (2015)
miR-135a Inhibits the Invasion and Migration of Esophageal Cancer Stem Cells through the Hedgehog Signaling Pathway by Targeting Smo
C. Yang (2019)See more